Loading
Life sciences · Journal article
Advanced Functional Materials · September 12, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT The nervous system is emerging as a central regulator of tumor initiation, progression, and therapeutic response. However, the dynamic mechanisms linking neural activity to malignant, immune, and barrier states remain difficult to dissect in vivo. Animal models capture key aspects of cancer neuroscience, but poorly control human‐specific multicellular interfaces, neural activity, secreted signals, and real‐time readouts. AI‐enabled organoid chip platforms offer a complementary route to reconstruct and interrogate the nerve‐tumor interface by integrating human‐derived organoids, microfluidic control, sensing, and computational modeling. Here we review advances in nerve‐tumor organoids and integrate relevant progress in microfluidics, in situ functional sensing, and AI‐driven modeling. These systems can enable controlled studies of perineural invasion, nerve‐mediated immune regulation, trans‐barrier drug responses, and longitudinal functional states. Key challenges include model standardization, long‐term stability, multimodal data interpretation, and clinical translation. AI‐enabled organoid chip platforms could help shift cancer neuroscience from descriptive observation towards perturbable, human‐relevant and data‐rich systems for mechanism discovery and precision therapy assessment.